Targeting growth factor supply in keratopathy treatment: comparison between maternal peripheral blood and cord blood as sources for the preparation of topical eye drops

Piera Versura, Marina Buzzi, Giuseppe Giannaccare, Adriana Terzi, Michela Fresina, Claudio Velati, Emilio C Campos, Piera Versura, Marina Buzzi, Giuseppe Giannaccare, Adriana Terzi, Michela Fresina, Claudio Velati, Emilio C Campos

Abstract

Background: Epitheliotrophic growth factors (GF) can be supplied topically to patients with severe keratopathy through a variety of blood-derived products. We compared GF content in adult peripheral blood serum (PB-S) and cord blood serum (CB-S) as potential sources of GF. To limit inter-individual variability the assessment was performed in maternal-child pairs at the time of delivery.

Material and methods: The amounts of epidermal GF (EGF), insulin-like GF (IGF), transforming GF-beta (TGF-β), vascular endothelial GF (VEGF) in CB units collected from the umbilical vein and PB from mothers (each group n=30) were estimated by enzyme-linked immunosorbent assays. Obstetric characteristics and haematological data were recorded from the archives of the Emilia Romagna Cord Blood Bank. Statistical evaluations were performed by Wilcoxon's test and correlations between variables were determined using Spearman's (ρ) coefficient; p-values <0.05 were considered statistically significant.

Results: EGF, TGF-β and VEGF levels were significantly higher in CB-S than in PB-S (median 1,254.4 vs 646.0 pg/mL, 51.3 vs 38.4 μg/mL and 686.8 vs 30 pg/mL, respectively; all p<0.0001) whereas IGF content was significantly higher in PB-S than in CB-S (159.9 vs 53.5 pg/mL, respectively; p<0.0001). In CB-S, the CD34(+) cell concentration appeared to be related to EGF, IGF and TGF-β levels whereas white blood cell count appeared to be related to EGF and TGF-β levels. VEGF levels showed no relation to the haematological parameters considered. Platelet counts were not related to GF level in either CB or PB.

Discussion: The GF content in the two blood sources was different, with CB containing larger amounts. Each GF selectively regulates cellular processes involved in corneal healing, so the use of PB or CB should be targeted to supply specific GF on the basis of the type and severity of the keratopathy.

Figures

Figure 1
Figure 1
A strong correlation was demonstrated between EGF and TGF-β levels in CB-S, (a) whereas no correlation among GF levels was found in PB-S. Moderate correlations were found for EGF levels in both sources (b), and for TGF-β in CB-S vs IGF-1 in PB-S (c). TGF-β: transforming GF-beta; CB-S: cord blood serum; EGF: epidermal growth factors; IGF: insulin-like growth factors; PB-S: peripheral blood serum.

Source: PubMed

3
Prenumerera